3rd Quarter - Report

VALENTE & ASSOCIATES for THE RABEN GROUP (ON BEHALF OF THE BOTANICAL EDUCATION ALLIANCE)

Period 3rd Quarter 2016 Filed Oct 13, 2016 Signed by CLAUDIA VALENTE

Official filing
Firm
VALENTE & ASSOCIATES
Client
THE RABEN GROUP (ON BEHALF OF THE BOTANICAL EDUCATION ALLIANCE)
Income
$20,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

In opposition to DEA's classification of Kratom as a Schedule I controlled substance

LobbyistCovered position, as disclosed
MARK WILLIAM RODGERS Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir., Cong. Rel. Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce
CLAUDIA BARKER VALENTE New Special Asst. to the Comptroller, U.S. DoD
J DANIEL WALSH Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Drug Enforcement Administration (DEA)

Consumer Issues/Safety/Products CSP

In opposition to DEA's classification of Kratom as a Schedule I controlled substance.

LobbyistCovered position, as disclosed
MARK WILLIAM RODGERS Deputy Dir., Cong. Rel.; Policy Dir., OPM; Dir. COng. Rel., Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce
CLAUDIA BARKER VALENTE New Special Asst. to the Comptroller, U.S. DoD
J DANIEL WALSH Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner

Contacted: HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); SENATE

Government Issues GOV

In opposition to DEA's classification of Kratom as a Schedule I controlled substance.

LobbyistCovered position, as disclosed
MARK WILLIAM RODGERS Deputy Dir., Cong. Rel.; Policy Dir., OMP; Dir. Cong. Rel., Smithsonian Inst.; Workforce Policy Coordinator, House Comm. on Education and the Workforce.
CLAUDIA BARKER VALENTE New Special Asst. to the Comptroller, U.S. DoD
J DANIEL WALSH Leg. Dir., Rep. Wayne Gilchrest; Leg. Asst., Rep. Jack Buechner

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.